According to foreign media reports, pharmaceutical company Bristol Myers Squibb (BMY.US) has signed an agreement to sell a 60% stake in its joint venture, Shanghai Bristol Myers Squibb Pharmaceutical Co., Ltd., as part of a long-term strategy.
Bristol Myers Squibb stated that it will continue to adjust resources to support the changing business needs of its global network but will not comment on the details of this transaction.
Shanghai Bristol Myers Squibb Pharmaceutical Co., Ltd. was established in 1982 and is the first Sino-American joint venture pharmaceutical company in China. The company supplies a variety of medications, including the oral antidiabetic drug Metformin and acetaminophen

Bristol Myers Squibb has signed an agreement to sell its 60% stake in Shanghai Bristol-Myers Squibb Pharmaceutical Co., Ltd., as part of a long-term strategy. The company was established in 1982 and is China's first Sino-American joint venture pharmaceutical company, primarily supplying oral antidiabetic drug metformin and acetaminophen, among others. Bristol Myers Squibb stated that it will continue to adjust resources to support global business needs but did not comment on the details of the transaction

百时美施贵宝出售中国合资公司 60% 股权